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Abstract. At the end of 2013, chikungunya virus (CHIKV) emerged in Saint Martin Island, Caribbean. The Asian
lineage was identified. Seven months after this introduction, the seroprevalence was 16.9% in the population of Saint
Martin and 39.0% of infections remained asymptomatic. This moderate attack rate and the apparent limited size of the
outbreak in Saint Martin could be explained by control measures involved to lower the exposure of the inhabitants. Other
drivers such as climatic factors and population genetic factors should be explored. The substantial rate of asymptomatic
infections recorded points to a potential source of infection that can both spread in new geographic areas and maintain an
inconspicuous endemic circulation in the Americas.
Chikungunya virus (CHIKV) is a virus of the family
Togaviridae, genus Alphavirus, transmitted by Aedes mosqui-
toes, first isolated in Tanzania in 1953.1 The burden of the
disease is related to persistent arthralgia that sometimes
outlasts the initial characteristic triad: fever, arthritis, and rash.2
CHIKV strains can be divided into three genetic lineages: west
African, east/central/south African (ECSA), and Asian line-
age.3Over the last decade, theECSA lineage becameprevalent
worldwide causing outbreaks in Europe, Africa, Indian Ocean,
and south Asia.4
Saint Martin Island is divided into two parts: in the north,
the French overseas territory of Saint Martin (∼36,000 inhab-
itants) and in the south, Sint Maarten (∼40,000), country of
the kingdom of the Netherlands. The first cases of CHIKV
infection in the Americas were identified in Saint Martin in
November 2013; the Asian lineage was involved.5 The spread
of CHIKV from human to human by the widely distributed
vector Aedes aegypti quickly evolved into an outbreak. By
February 2014, weekly clinical cases of CHIKV infections
diagnosed by general practitioners peaked at 226 (Figure 1).
Since March, CHIKV circulation decreased in Saint Martin
to a weekly average of 42 clinical cases.
In early July, with the beginning of the wet season, we
expected an increased activity ofA. aegypti vector mosquitoes.
To anticipate the dynamics of chikungunya in Saint Martin
and inform decision making, we conducted a serosurvey to
assess the level of herd immunity and the proportion of
asymptomatic infections.
For this serosurvey, we constituted a convenience sample,
taking advantage of the sole laboratory of Saint Martin.
Between July 3 and 8, 2014 (Figure 1), all individuals attend-
ing the laboratory for any type of biological analysis were
offered a serological test for CHIKV. Only people living in
Saint Martin for over 6 months were included. Participants
or their legal guardian signed an informed consent and com-
pleted a questionnaire collecting information on gender, age,
and possibly symptoms of CHIKV infection (joint pain and
fever) during the last 6 months. A 5 mL sample of venous
blood was collected from adults and 2 mL for children (those
less than 6 months of age were excluded). The Advisory
Ethical Committee of Paris and the French Data Protection
Authority approved the study. Sera were collected and kept
at −20°C for 1–6 days before being sent in dry ice to the
regional French National Reference Center for Arboviruses,
Institut Pasteur de Guyane. Both IgM and IgG anti-CHIKV-
specific antibodies were screened in sera using an “in-house”
enzyme-linked immunosorbent assay (IgM antibody capture
ELISA and ELISA, respectively) as described by Talarmin
and others.6 If IgM or IgG were detected, the serological test
was considered positive.
We performed statistical analysis using STATA version 10
(www.stata.com). After a direct standardization by gender
and age using 2010 Census data of the French National
Institute of Statistics and Economic Studies, we estimated
the seroprevalence and the proportion of asymptomatic
infections in the population.
During the survey, 203 individuals were included (participa-
tion rate = 93%) and 42 (20.69%) tested positive for anti-CHIKV
antibodies (19 for IgM, 36 for IgG, and 13 for both). Table 1
presents standardized estimates of the seroprevalence in Saint
Martin inhabitants. We estimated that, in July 2014, the sero-
prevalence of CHIKV infection in the general population of
Saint Martin was 16.9% (95% confidence interval [CI] = 11.6–
22.1%]. Among the 42 seropositive individuals, 17 did not report
any CHIKV-related symptoms. Thus, the infection remained
asymptomatic for 39.0% (95% CI = 23.9–54.1%) of infected
individuals in the population.
This is the first CHIKV serosurvey in the Western
Hemisphere since the 2013 emergence in the Caribbean.
Seven months after this emergence, we estimated that
16.9% of Saint Martin inhabitants were infected. This mod-
erated herd immunity indicated an intermediate stage of the
outbreak in July 2014.
Although a direct standardization by gender and age has
been applied to limit the selection bias in patient recruitment,
an underestimation of CHIKV seroprevalence in population
could not be excluded. Access to health care could be easier
for people coming to the laboratory than in the general popu-
lation but should be unlikely as French regulation ensures a
broad access to health care. Even if the geographic distribution
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of the individuals coming to the laboratory was not consid-
ered, CHIKV was widespread in all districts of Saint Martin.
CHIKV circulated in the whole island; the seroprevalence
should be comparable for Sint Maarten and Saint Martin
because of the small size of the Island and the lack of physical
or geographical separation between both countries facilitating
population mixing. However, no surveillance data are avail-
able for Sint Maarten, hence the attack rate cannot be directly
extrapolated for Sint Maarten.
Seroprevalence reported in other surveys varied between
10.2% and 75% (Table 2). Except for the 2007 outbreak
in Italy,8 the seroprevalence observed in Saint Martin in
July 2014 was the lowest recorded. This moderate attack rate
was pointing the persistence of the viral circulation in the fol-
lowing months (confirmed by the surveillance data; Figure 1).
However, comparison with other surveys should be cautious
because data were collected in different settings and at dif-
ferent times throughout the course of the outbreaks (elapsed
time between emergence and serosurvey often missing).
The reason explaining the moderate seroprevalence in Saint
Martin may lie in the local determinants of transmission of the
Asian lineage with regard to the vectors, environment, and
human population.
First, transmission efficiency of the local vector, Ae. aegypti,
for the Asian lineage should be considered. Remarkably, out-
breaks of Asian lineage associated with Ae. aegypti were lim-
ited in New Caledonia (33 and 30 autochthonous cases, in
2011 and 2013, respectively)15,16 and in Malaysia (1998 and
2006, respectively)9 whereas the 2009 ECSA lineage had a
nationwide diffusion.17 However, a recent study has demon-
strated that Ae. aegypti populations from Saint Martin were
well adapted to CHIKV and transmitted efficiently both
Asian and ECSA lineages.18
Different climatic factors (e.g., ambient temperature, daily
fluctuation of temperature, and pluviometry) could have driven
outbreak courses resulting in different attack rates. Recently,
a model explaining autochthonous transmission of CHIKV in
the Americas with climatic drivers (mean temperature and
precipitations) was created.19 For instance, the potential link
between the highest rainfall level of October and November
(http://www.meteofrance.com/) and the peak of cases observed
in December and January (2013 and 2014; Figure 1) should
be investigated.
Besides, the moderate seroprevalence observed in Saint
Martin could be indicative of the efficiency of control mea-
sures applied promptly after the emergence and throughout
the outbreak (i.e., insecticide treatment, breeding sites destruc-
tion, and recommendations of personal protection against mos-
quitoes). Sensitized by the CHIKV outbreak in La Reunion,
the French public health authorities set up in 2013 a pre-
paredness and response plan for CHIKV introduction in Saint
Martin,20 which may have slow down the dissemination of the
virus in the population.
Our results indicated that 40.5% of the infected people did
not reported chikungunya-like symptoms within the 6 months
preceding the study (39.0% of asymptomatic cases in the gen-
eral population of Saint Martin). Although a recall bias can-
not be excluded, severe arthralgias caused by CHIKV are
usually memorable.
The proportion of asymptomatic infections reported in
other surveys was overall substantially lower than the propor-
tion obtained in Saint Martin (Table 2). However, high rate of
asymptomatic infections were recorded with ECSA lineages
in Thailand and Kenya (47.1% and 45.1%, respectively).12,14
Manimunda and others suggested an association between
the overall seroprevalence in a population and the propor-
tion of unapparent infection. Indeed intensity of transmission
FIGURE 1. Number of weekly incident cases of chikungunya reported by the general practitioner surveillance system, Saint Martin.
TABLE 1
Seroprevalence of IgG and/or IgM against CHIKV in Saint Martin,
July 2014
Sample size
n (%)
Population of Saint
Martin N (%)
Standardized
seroprevalence (%)*
Age group
6 months to
29 years
37 (18.2) 18,197 (0.49) 14.8 (3.1–26.5)
30–44 years 55 (27.1) 9,070 (0.25) 11.7 (3.0–20.4)
45–59 years 66 (32.5) 6,726 (0.18) 21.6 (11.4–31.7)
≥ 60 years 45 (22.2) 2,983 (0.08) 34.5 (20.5–48.7)
Gender
Men 74 (36.5) 17,519 (0.47) 18.6 (9.5–27.8)
Women 129 (63.5) 19,461 (0.53) 15.2 (8.9–21.5)
Total 203 (100) 36,980 16.9 (11.6–22.1)
CHIKV = chikungunya virus.
*Sex and age adjusted.
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in a population, loosely approximated by the attack rate,
could be inversely associated to the proportion of unap-
parent infection.21
The 16.9% seroprevalence estimated gives a clearer pic-
ture of susceptible people who could still be naive (83.1%)
in July 2014. Because of that large part of naive population
and frequent arrival of susceptible among tourists, control
efforts should be pursued. The strengthening of the viral
circulation observed in December 2014 has indicated the
possibility of other epidemic waves. Moreover, our study
highlighted a substantial rate of asymptomatic infections that
may play a significant role in maintaining the transmission.22
A low endemic circulation of the Asian lineage in the
Americas could not be excluded as observed in Malaysia.9
Asian CHIKV lineage is currently disseminating in the
Americas23 and ECSA have emerged in Brazil.24 CHIKV
outbreaks caused by ECSA and Asian lineages could become
common wherever competent vectors, Ae. aegypti or Aedes
albopictus, are established in the Western Hemisphere. Our
study highlighted the need of a preparedness plan to mitigate
the dissemination of the CHIKV. A particular attention should
be paid to the substantial rate of asymptomatic infections
recorded. Even if difficult to registered by the epidemiologi-
cal surveillance system, asympytomatic individuals are still a
potential source of infection that can spread in new geo-
graphic area.14 Finally, further studies are needed in the
Americas to monitor closely for each CHIKV lineage: the
spread, the related proportion of unapparent infection, and
the transmission efficiency by the local vector mosquitoes.
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